AR and prostate cancer: We also found that AR was reexpressed in xenograft tumors derived from both CSCs (Supplementary Fig. 3c) and parent cells (Supplementary Fig. 3d) of PC3, further demonstrating that the candidate CSCs are able to differentiate in vivo to generate tumors with features of prostate cancer.